Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor (Q40733816)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor |
scientific article |
Statements
1 reference
Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor (English)
1 reference
LeMaistre CF
1 reference
Meneghetti C
1 reference
Rosenblum M
1 reference
Reuben J
1 reference
Parker K
1 reference
Shaw J
1 reference
Deisseroth A
1 reference
Woodworth T
1 reference
Parkinson DR
1 reference
1 May 1992
1 reference